These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 10276741)
1. What's in a name? Generic vs brand name drugs. Levin AA Health PAC Bull; 1986 Jun; 16(5):37, 39. PubMed ID: 10276741 [No Abstract] [Full Text] [Related]
2. Generic vs. brand name drugs--quality, not cost, is key issue. Stetler CJ Internist; 1979 May; 20(4):9-10, 12. PubMed ID: 10242133 [No Abstract] [Full Text] [Related]
3. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality? Marsh DA; Hoar ME Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245 [TBL] [Abstract][Full Text] [Related]
4. Generic vs. brand name drugs--defining and enforcing standards. Lasagna LC Internist; 1979 May; 20(4):11, 13. PubMed ID: 10316827 [No Abstract] [Full Text] [Related]
5. Status of generic substitution: problematic drug classes reviewed. Ross MB Hosp Formul; 1989 Aug; 24(8):441-4, 447-9. PubMed ID: 10294356 [TBL] [Abstract][Full Text] [Related]
6. Generic vs. brand name drugs--patients, pharmacists, physicians: caught in the middle. Felch WC Internist; 1979 May; 20(4):3-5. PubMed ID: 10242131 [No Abstract] [Full Text] [Related]
7. What's in a name? Generics and the persistence of the pharmaceutical brand in American medicine. Greene JA J Hist Med Allied Sci; 2011 Oct; 66(4):468-506. PubMed ID: 20858701 [TBL] [Abstract][Full Text] [Related]
8. Generic and alternative brand-name pharmaceutical equivalents: select with caution. Hendeles L; Hochhaus G; Kazerounian S Am J Hosp Pharm; 1993 Feb; 50(2):323-9. PubMed ID: 8480793 [No Abstract] [Full Text] [Related]
9. Branded drug reformulation: the next brand vs. generic antitrust battleground. Amoresano GV Food Drug Law J; 2007; 62(1):249-56. PubMed ID: 17444032 [No Abstract] [Full Text] [Related]
10. Generics still a favorite Rx for savings. Wagner M Mod Healthc; 1990 May; 20(21):26-8, 30, 32-3. PubMed ID: 10104890 [TBL] [Abstract][Full Text] [Related]
11. FDA drug list: key to generic substitution. FDA Consum; 1979 Feb; 13(1):15-7. PubMed ID: 10308816 [TBL] [Abstract][Full Text] [Related]
12. What's the problem with generic antiepileptic drugs?: a call to action. Berg MJ Neurology; 2007 Apr; 68(16):1245-6. PubMed ID: 17438211 [No Abstract] [Full Text] [Related]
13. Initial responses to recommendations of the Blue Ribbon Committee on Generic Medicines. Heller WM Am J Hosp Pharm; 1993 Feb; 50(2):318-22. PubMed ID: 8480792 [No Abstract] [Full Text] [Related]
15. Brand-name drug manufacturers risk antitrust violations by slowing generic production through patent layering. Paine CS Seton Hall Law Rev; 2003; 33(2):479-510. PubMed ID: 12715807 [No Abstract] [Full Text] [Related]
16. Current issues in the pioneer versus generic drug wars. Safir PO Food Drug Law J; 1995; 50(2):335-9. PubMed ID: 10343002 [No Abstract] [Full Text] [Related]